MAQAF Quote, Financials, Valuation and Earnings

Brambles has a net margin of -- compared to Atlas Arteria's net margin of --. Atlas Arteria's return on equity of 4.67% beat Brambles's return on equity of 25.37%.

Atlas Arteria has a consensus price target of --, signalling downside risk potential of --. On the other hand Brambles has an analysts' consensus of -- which suggests that it could fall by --. Given that Atlas Arteria has higher upside potential than Brambles, analysts believe Atlas Arteria is more attractive than Brambles.

Atlas Arteria has a beta of 1.196, which suggesting that the stock is 19.55% more volatile than S&P 500. In comparison Brambles has a beta of 0.914, suggesting its less volatile than the S&P 500 by 8.554%.

Atlas Arteria has a quarterly dividend of $0.14 per share corresponding to a yield of 9.81%. Brambles offers a yield of 2.86% to investors and pays a quarterly dividend of $0.39 per share. Atlas Arteria pays 179.41% of its earnings as a dividend. Brambles pays out 52.06% of its earnings as a dividend. Brambles's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Atlas Arteria's is not.

Atlas Arteria quarterly revenues are --, which are smaller than Brambles quarterly revenues of --. Atlas Arteria's net income of -- is lower than Brambles's net income of --. Notably, Atlas Arteria's price-to-earnings ratio is 20.23x while Brambles's PE ratio is 21.60x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Atlas Arteria is 43.33x versus 2.57x for Brambles. Usually stocks with elevated PS ratios are considered overvalued.

EESTech has a net margin of -- compared to Atlas Arteria's net margin of --. Atlas Arteria's return on equity of 4.67% beat EESTech's return on equity of --.

Atlas Arteria has a consensus price target of --, signalling downside risk potential of --. On the other hand EESTech has an analysts' consensus of -- which suggests that it could fall by --. Given that Atlas Arteria has higher upside potential than EESTech, analysts believe Atlas Arteria is more attractive than EESTech.

Atlas Arteria has a beta of 1.196, which suggesting that the stock is 19.55% more volatile than S&P 500. In comparison EESTech has a beta of -0.861, suggesting its less volatile than the S&P 500 by 186.114%.

Atlas Arteria has a quarterly dividend of $0.14 per share corresponding to a yield of 9.81%. EESTech offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Atlas Arteria pays 179.41% of its earnings as a dividend. EESTech pays out -- of its earnings as a dividend.

Atlas Arteria quarterly revenues are --, which are smaller than EESTech quarterly revenues of --. Atlas Arteria's net income of -- is lower than EESTech's net income of --. Notably, Atlas Arteria's price-to-earnings ratio is 20.23x while EESTech's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Atlas Arteria is 43.33x versus 0.41x for EESTech. Usually stocks with elevated PS ratios are considered overvalued.

Globavend Holdings has a net margin of -- compared to Atlas Arteria's net margin of --. Atlas Arteria's return on equity of 4.67% beat Globavend Holdings's return on equity of 73.61%.

Atlas Arteria has a consensus price target of --, signalling downside risk potential of --. On the other hand Globavend Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that Atlas Arteria has higher upside potential than Globavend Holdings, analysts believe Atlas Arteria is more attractive than Globavend Holdings.

Atlas Arteria has a beta of 1.196, which suggesting that the stock is 19.55% more volatile than S&P 500. In comparison Globavend Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Atlas Arteria has a quarterly dividend of $0.14 per share corresponding to a yield of 9.81%. Globavend Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Atlas Arteria pays 179.41% of its earnings as a dividend. Globavend Holdings pays out 136.85% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Atlas Arteria quarterly revenues are --, which are smaller than Globavend Holdings quarterly revenues of --. Atlas Arteria's net income of -- is lower than Globavend Holdings's net income of --. Notably, Atlas Arteria's price-to-earnings ratio is 20.23x while Globavend Holdings's PE ratio is 5.31x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Atlas Arteria is 43.33x versus 0.51x for Globavend Holdings. Usually stocks with elevated PS ratios are considered overvalued.

GWA Group has a net margin of -- compared to Atlas Arteria's net margin of --. Atlas Arteria's return on equity of 4.67% beat GWA Group's return on equity of 12.33%.

Atlas Arteria has a consensus price target of --, signalling downside risk potential of --. On the other hand GWA Group has an analysts' consensus of -- which suggests that it could fall by --. Given that Atlas Arteria has higher upside potential than GWA Group, analysts believe Atlas Arteria is more attractive than GWA Group.

Atlas Arteria has a beta of 1.196, which suggesting that the stock is 19.55% more volatile than S&P 500. In comparison GWA Group has a beta of -0.097, suggesting its less volatile than the S&P 500 by 109.68%.

Atlas Arteria has a quarterly dividend of $0.14 per share corresponding to a yield of 9.81%. GWA Group offers a yield of 6.83% to investors and pays a quarterly dividend of $0.22 per share. Atlas Arteria pays 179.41% of its earnings as a dividend. GWA Group pays out 96.11% of its earnings as a dividend. GWA Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Atlas Arteria's is not.

Atlas Arteria quarterly revenues are --, which are smaller than GWA Group quarterly revenues of --. Atlas Arteria's net income of -- is lower than GWA Group's net income of --. Notably, Atlas Arteria's price-to-earnings ratio is 20.23x while GWA Group's PE ratio is 15.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Atlas Arteria is 43.33x versus 1.44x for GWA Group. Usually stocks with elevated PS ratios are considered overvalued.